Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Front Immunol ; 11: 1822, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32983090

RESUMO

Innate immunity is one of the main protection mechanisms against viral infections, but how this system works at the maternal-fetal interface, especially during HIV infection, is still poorly known. In this study, we investigated the relationship between pregnancy and innate mechanisms associated with HIV immunity by evaluating the expression of DAMPs, inflammasome components and type I/III IFNs in placenta and serum samples from HIV-infected mothers and exposed newborns. Our results showed that most of these factors, including HMGB1, IL-1, and IFN, were increased in placental villi from HIV-infected mothers. Curiously, however, these factors were simultaneously repressed in serum from HIV-infected mothers and their exposed newborns, suggesting that pregnancy could restrict HIV immune activation systemically but preserve the immune response at the placental level. An effective local antiviral status associated with a suppressed inflammatory environment can balance the maternal immune response, promoting homeostasis for fetal development and protection against HIV infection in neonates.


Assuntos
Alarminas/metabolismo , Infecções por HIV/imunologia , HIV/imunologia , Imunidade Inata , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Mediadores da Inflamação/metabolismo , Placenta/imunologia , Adolescente , Adulto , Alarminas/genética , Brasil , Feminino , Sangue Fetal/imunologia , Sangue Fetal/virologia , HIV/patogenicidade , Infecções por HIV/diagnóstico , Infecções por HIV/virologia , Proteína HMGB1/metabolismo , Interações Hospedeiro-Patógeno , Humanos , Recém-Nascido , Interferons/metabolismo , Interleucina-1/metabolismo , Mães , Placenta/metabolismo , Placenta/virologia , Gravidez , Regulação para Cima , Adulto Jovem
2.
Braz J Infect Dis ; 11(2): 261-6, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17625774

RESUMO

Colonization by Group B Streptococcus (GBS) is highly prevalent among pregnant women, with prevalence rates ranging between 4% and 30%. The infection may be transmitted vertically and may result in serious neonatal consequences. In the period from November 2003 to May 2004, a cross-sectional study was carried out among 316 parturients at the Jundiaí Teaching Hospital to establish the prevalence of genital GBS colonization, to identify the factors associated with colonization and the characteristic phenotypes of these streptococci. Samples from rectal and vaginal areas were collected for selective culture in Todd-Hewitt broth. Susceptibility to 7 antimicrobial agents was tested using the antibiotic diffusion disk technique, and the isolated strains were classified using specific antisera. The prevalence of GBS colonization was 14.6%. No strain was resistant to penicillin, ampicillin, erythromycin or nitrofurantoin. The majority of strains were sensitive to cephalothin. Greatest resistance was to gentamicin (76.1%), followed by clindamycin (17.4%). The most frequent serotype was Ib (23.9%), followed by serotypes II and Ia (19.6% and 17.4%, respectively). There was no correlation between serotype and greater antimicrobial resistance. In conclusion, the prevalence of GBS in parturients was high and penicillin continues to be the drug of choice for intrapartum prophylaxis. The most frequent serotype (Ib) found in this study differs from those found in the majority of studies carried out in other countries, revealing the need to identify prevalent serotypes in each region so that specific vaccines can be designed.


Assuntos
Antibacterianos/farmacologia , Portador Sadio/microbiologia , Complicações Infecciosas na Gravidez/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus agalactiae/isolamento & purificação , Adulto , Estudos Transversais , Feminino , Humanos , Testes de Sensibilidade Microbiana , Fenótipo , Gravidez , Reto/microbiologia , Fatores de Risco , Sorotipagem , Streptococcus agalactiae/classificação , Streptococcus agalactiae/efeitos dos fármacos , Vagina/microbiologia
4.
BJOG ; 112(9): 1284-90, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16101609

RESUMO

OBJECTIVE: To compare the effectiveness of immediate induction of labour with vaginal misoprostol versus expectant management for 24 hours followed by oxytocin induction in women with premature rupture of membranes at term (term PROM). DESIGN: An open, randomised, controlled trial. SETTING: Public university hospital in Campinas City, Brazil. POPULATION: One hundred and fifty pregnancies, half of them allocated to each group. METHODS: Statistical analysis used Student's t test, the chi2 test, Fisher's exact test, survival analysis and risk ratio estimates with 95% CI. MAIN OUTCOME MEASURES: Latency period, recruitment to delivery period, period of hospitalisation, mode of delivery, contractility pattern, fetal wellbeing, labour and delivery complications, neonatal and maternal morbidity. RESULTS: Both groups had similar general characteristics, but the misoprostol group had a significantly shorter latency period (9.4 vs 15.8 hours), a shorter time interval from recruitment to delivery (18.9 vs 27.5 hours), a shorter period of maternal hospitalisation and a slightly higher proportion of alterations of contractility when compared with the expectant group. Caesarean section rates were 20% in the misoprostol group and 30.7% in the other. There were no differences between them regarding fetal wellbeing, complications during labour and delivery and neonatal or postpartum maternal morbidity. Within 24 hours, 44% of women had delivered in the expectant group against 73.3% in the misoprostol group. CONCLUSIONS: Immediate labour induction with misoprostol in cases of term PROM shortens the latency period, the total time between recruitment to delivery and the time of maternal hospitalisation, increasing the occurrence of alterations of contractility without any maternal and perinatal outcomes disadvantages.


Assuntos
Abortivos não Esteroides , Ruptura Prematura de Membranas Fetais , Trabalho de Parto Induzido/métodos , Misoprostol , Adolescente , Adulto , Índice de Apgar , Cesárea , Feminino , Humanos , Tempo de Internação , Contração Miocárdica/efeitos dos fármacos , Gravidez , Resultado da Gravidez , Fatores de Risco , Comprimidos
5.
Braz. j. infect. dis ; 11(2): 261-266, Apr. 2007. tab, graf
Artigo em Inglês | LILACS | ID: lil-454727

RESUMO

Colonization by Group B Streptococcus (GBS) is highly prevalent among pregnant women, with prevalence rates ranging between 4 percent and 30 percent. The infection may be transmitted vertically and may result in serious neonatal consequences. In the period from November 2003 to May 2004, a cross-sectional study was carried out among 316 parturients at the Jundiaí Teaching Hospital to establish the prevalence of genital GBS colonization, to identify the factors associated with colonization and the characteristic phenotypes of these streptococci. Samples from rectal and vaginal areas were collected for selective culture in Todd-Hewitt broth. Susceptibility to 7 antimicrobial agents was tested using the antibiotic diffusion disk technique, and the isolated strains were classified using specific antisera. The prevalence of GBS colonization was 14.6 percent. No strain was resistant to penicillin, ampicillin, erythromycin or nitrofurantoin. The majority of strains were sensitive to cephalothin. Greatest resistance was to gentamicin (76.1 percent), followed by clindamycin (17.4 percent). The most frequent serotype was Ib (23.9 percent), followed by serotypes II and Ia (19.6 percent and 17.4 percent, respectively). There was no correlation between serotype and greater antimicrobial resistance. In conclusion, the prevalence of GBS in parturients was high and penicillin continues to be the drug of choice for intrapartum prophylaxis. The most frequent serotype (Ib) found in this study differs from those found in the majority of studies carried out in other countries, revealing the need to identify prevalent serotypes in each region so that specific vaccines can be designed.


Assuntos
Adulto , Feminino , Humanos , Gravidez , Antibacterianos/farmacologia , Portador Sadio/microbiologia , Complicações Infecciosas na Gravidez/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus agalactiae/isolamento & purificação , Estudos Transversais , Testes de Sensibilidade Microbiana , Fenótipo , Fatores de Risco , Reto/microbiologia , Sorotipagem , Streptococcus agalactiae/classificação , Streptococcus agalactiae/efeitos dos fármacos , Vagina/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA